Compare PRA & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRA | SPRY |
|---|---|---|
| Founded | 1976 | 2015 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | N/A | N/A |
| Metric | PRA | SPRY |
|---|---|---|
| Price | $24.40 | $9.46 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $22.50 | ★ $35.00 |
| AVG Volume (30 Days) | 581.1K | ★ 1.3M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.24 | $119.97 |
| P/E Ratio | $37.22 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.90 | $6.66 |
| 52 Week High | $24.66 | $18.90 |
| Indicator | PRA | SPRY |
|---|---|---|
| Relative Strength Index (RSI) | 57.30 | 43.59 |
| Support Level | $24.25 | $8.61 |
| Resistance Level | $24.66 | $10.11 |
| Average True Range (ATR) | 0.17 | 0.56 |
| MACD | 0.01 | -0.08 |
| Stochastic Oscillator | 50.53 | 40.38 |
ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in five segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, Lloyd's Syndicate, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.